Article
Resistance to novel drug classes
8 Oct 2009
Abstract excerpt
PURPOSE OF REVIEW: Understanding the mechanisms that underlie resistance development to novel drugs is essential to a better clinical management of resistant viruses and to prevent further resistance development and spread. RECENT FINDINGS: Integrase inhibitors and CCR5 antagonists are the more recent antiretroviral classes developed. The HIV-1 integrase, responsible for the chromosomal integration of the newly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
